tirzepatide approved for obesity enhances weight loss with sustained treatment but discontinuation leads to weight regain GLP-1 Medications for Weight Loss:

Nat Med 30 (1): 257-264, 2024

Clinical evidence: proven results in male studies Recent clinical trials have demonstrated PT-141s effectiveness specifically for men: In both studies, the erectile response induced by PT-141 administration was statistically significant compared to placebo at doses exceeding 7 mg, with the first erection occurring roughly 30 minutes after administration

Gramlich claimed compounded semaglutide with L-Carnitine injection was FDA-approved for weight loss when it wasnt, according to his settlement with the California State Board of Pharmacy

Dec 2020;10(6):1345-1357

2017 Nov;174(11):1325-1348

More importantly for recomposition purposes, participants maintained or improved metabolic rate throughout treatment